Reini Hurme

Zora Biosciences (Finland)

Papers

1

Total Citations

52

H-Index

1

About

Reini Hurme is a biomedical researcher whose work centers on the intersection of lipid metabolism, cardiovascular disease, and environmental toxicology. Her most cited study, "Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice" (2012, 52 citations), represents a significant contribution to understanding how cigarette smoke exposure alters lipid profiles to promote atherosclerosis. Using an apolipoprotein E-deficient mouse model, Hurme demonstrated that smoking disrupts the lipidome in ways that accelerate plaque formation, providing mechanistic insight into how environmental factors drive cardiovascular risk. This work has been influential in linking lipidomics with toxicology, offering a molecular framework for public health interventions. Hurme's research is notable for its translational potential, bridging basic lipid science with real-world exposures. Her findings have been cited in studies on smoking-related cardiovascular disease, lipid metabolism, and the development of targeted therapies. For students and researchers, Hurme exemplifies how careful experimental design in animal models can illuminate the pathways connecting lifestyle factors to chronic disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
Modulation of atherogenic lipidome by cigarette smoke in apolipoprotein E-deficient mice
52 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Zora Biosciences (Finland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago